glp-1 microbiome Understanding the Crucial Role of Your Gut in drug effectiveness, utilization, and tapering A Specific Gut Microbiota Dysbiosis

1 Introduction The goal in growth-promoting therapy in children with growth disorders is to increase the child's growth rate and adult height while approaching a physiological pattern of growth hormone (GH) secretion

Medical safety (25%): When you don't have a PCP managing your broader health, the quality of medical oversight from your GLP-1 provider matters more

The fourth error is insufficient protocol duration

Discussion This study adds to the limited available data on the use of semaglutide in patients with advanced CKD and provides insight over a prolonged follow-up period exceeding three years (median 1,187 days [IQR 6021,442]), with the majority of patients receiving maintenance hemodialysis (58.8%)